General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Sanford Health · with The Leona M. and Harry B. Helmsley Charitable Trust, Pacific Northwest Research Institute · NCT04477928
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 17 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 33000
- US sites recruiting
- 4
- Study start
- July 17, 2020
- Record last updated
- March 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.
Being studied: Sera and whole blood sampling; Differential Gene Expression (DGE)
Conditions: Type 1 Diabetes; Celiac Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Newborn Entry: Viable, term infants, defined as 36 weeks gestation by either dates or ultrasound who are born to pregnant women, 18 years or older, who are willing and able to provide informed consent (IC) prior to the onset of active labor. Who are born at a Sanford Health Hospital and plan to have routine well-child care at a Sanford Clinic
- Pediatric Entry: Children less than 6 years of age who receive their routine care at a Sanford facility and whose parents are able to provide IC.
- Adolescent Entry: Children, ages 9-16 years old, who receive their routine care at a Sanford facility and whose parents are able to provide IC.
- Siblings of children known to have T1D-relevant antibodies; ages 6 to 17 years old who receive care at a Sanford clinic
- Have an active MyChart account (with proxy access).
Exclusion Criteria
- Subject is in the opinion of the investigator, unable to comply with the requirements of the study protocol.
- Children known to have T1D
Recruiting US locations
Sanford Bemidji Region Clinics
Bemidji, MN 56601
Site contact: Ann Mays, RN, CPN · 605-312-6052 · ann.mays@sanfordhealth.org
Sanford Bismarck Region Clinics
Bismarck, ND 58501
Site contact: Ann Mays, RN, CPN · 605-312-6052 · ann.mays@sanfordhealth.org
Sanford Fargo Region Clinics
Fargo, ND 58112
Site contact: Ann Mays · 605-312-6052 · ann.mays@sanfordhealth.org
Sanford Sioux Falls Region Clinics
Sioux Falls, SD 57105
Site contact: Ann Mays · 6053126052 · ann.mays@sanfordhealth.org
Study contacts (from the official record)
- Ann Mays, RN, CPN · 605-312-6052 · ann.mays@sanfordhealth.org
Similar studies in Minnesota
All diabetes studies in Minnesota →- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Alcamena Stem Cell Therapeutics
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Mankato, MN + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Minneapolis, MN + 121 other US sites
- Eligibility basics
- Ages 55+